UR9 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Clinuvel Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 5.272 EUR 2.65%

Market Cap: €795.7m

C	Clinuvel Pharmaceuticals Ltd XMUN:UR9	AU
I	Iss A/S XMUN:QJQ	DK
B	Berlian Laju Tanker Tbk PT IDX:BLTA	ID
E	Enagas SA XMUN:EG4	ES
R	Renatus Tactical Acquisition I Corp NASDAQ:RTAC	KY
C	Canadian Pacific Railway Ltd F:PC8	CA
H	Hyatt Hotels Corp XMUN:1HTA	US
	BBTV Holdings Inc TSX:BBTV	CA
P	Pacific Pipe PCL SET:PAP	TH

Profitability Summary

Clinuvel Pharmaceuticals Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

95%

Strong 3Y Average Gross Margin

98%

Gross Margin is Increasing

94% > 95%

Exceptional Operating Margin

45%

Strong 3Y Average Operating Margin

52%

Declining Operating Margin

56% > 45%

Exceptional Net Margin

34%

Strong 3Y Average Net Margin

38%

Declining Net Margin

39% > 34%

Exceptional Free Cash Flow Margin

42%

Strong 3Y Average Free Cash Flow Margin

38%

Declining Free Cash Flow Margin

46% > 42%

Positive ROE

14%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

108%

Declining ROIC

122% > 108%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.